ArticleMolecular therapy oncolytics2021

R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway.

Yuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.